PRK
PRK, or photorefractive keratectomy, has
been performed worldwide to correct myopia, hyperopia and astigmatism.
PRK involves removing the epithelium, the surface layer of the
cornea. Then a computer-controlled excimer laser reshapes the
cornea of the affected eye. Anesthetic drops in the eye ensure
that the patient experiences as little discomfort as possible.
While the long-term visual results achieved are predictable
and stable, patients experience discomfort for 24-48 hours while
their epithelium regenerates. Additionally, the initial visual
recovery associated with PRK is not a fast as with LASIK, although
data demonstrate that visual recovery is the same as with LASIK
by approximately 3-6 months. Typically both eyes are not treated
at the same time, though they may be. Patients typically wear
bandage contact lenses for pain reduction for a few days while
the epithelial tissue regenerates and use postoperative eye
drops for up to four months. As with any surgery, there are
risks involved. The complications associated with PRK are similar
to those with LASIK. Patients should discuss that information
in detail with their surgeons.
LASEK
A slight variation on the traditional LASIK
procedure is becoming available, LASEK. This procedure may
be an option for patients who are not good candidates for
the traditional procedure.
LASEK is a relatively new surgery that
utilizes a trephine to create an epithelial flap (as opposed
to a deeper stromal flap with LASIK) and an alcohol solution
to preserve the epithelial cells. Once the epithelial flap
is created and lifted, the treatment proceeds as for traditional
PRK, with light smoothing at its conclusion. Then, the epithelial
flap is repositioned with a small spatula.
LASEK preserves more corneal tissue, on
average, than a typical LASIK procedure. Therefore, for patients
who have thin corneas, LASEK may offer a safer alternative
than LASIK.
Several small peer-reviewed studies have recently been published
about the LASEK procedure.1-5
All have concluded that this technique has the potential for
use within the clinical practice, noting patients achieved
results similar to those achieved with LASIK or PRK. All also
noted that additional long-term studies were needed to confirm
these early results. As more ophthalmologists are trained
in the procedure and offer this technique as an alternative
to patients, we expect to see more studies collaborating these
initial results.
The FDA approves drugs and devices, not specific surgeries.
However, the FDA evaluates the safety and efficacy of a device
within the context of studies that have been done on a particular
procedure, like PRK or LASIK.
On those lasers that have earned approval based on PRK or
LASIK data, LASEK is permitted as a practice of medicine.
The use of devices during a procedure deemed a practice-of-medicine
is called an "off label" use of these devices. Because
the approved lasers and trephines have proven safe and effective
in other procedures, ophthalmologists may use them off-label
if they feel it is in their patients' best interest to do
so.
We have provided Tough Questions for Doctors on our website
for some time. We have listed below a few more that will be
of assistance if you are considering LASEK.
- What training have you received on this particular
surgical procedure?
- What should my expectations be for healing
at one day? one week? one month? etc.
- Are there any quality of vision issues I
need to understand? (risk of glare/halos, decreased contrast
sensitivity, etc)
- What complications are associated with this
procedure? How are they different from those of LASIK or
PRK?
- What about my eyes makes me a good candidate
for LASEK?
- What is the advantage of this procedure over
LASIK for me?
As always, there are no right or wrong answers
to these questions; however the answers should be of assistance
in your evaluation.
The US FDA LASIK web site provides a checklist for prospective
refractive surgery patients. You should carefully review those
questions. We suggest you review that list and ask yourself
the following:
- Are the risks associated with the surgery
worth the potential benefit derived from the surgery?
- Am I generally a risk taker?
- Do I generally adopt new technology early
on, before others, or do I wait until it is more mainstream?
In sum, LASEK may offer patients with thin corneas
a viable option to preserve more corneal tissue. However,
the LASEK procedure is relatively new and is an off-label
use of the excimer laser. Patients should be sure to discuss
this option fully with their ophthalmologist.
Laser
Thermal Keratoplasty (LTK)
LTK has been approved by the US FDA for temporary reduction
of moderate hyperopia (+0.75D to +2.50D) with or without mild
astigmatism (up to 0.75D). Patients must be 40 years or older.
The procedure produces a change in the refractive power and
properties of the cornea by using the heat produced by holmium
laser light to modify the structure of the cornea's collagen
fibers.
LTK involves the strategic placement of 16 laser spots onto
the peripheral cornea. First the eye is numbed with anesthetic
drops and held open with an eyelid holder so that the tear
film can dry for 3 minutes before the laser is applied. The
laser application itself takes less than 3 seconds per eye.
The treatment thermally contracts the tissue, causing the
central cornea to steepen. A bandage soft contact lens is
usually placed on the eye until the following day. They eye
may have some irritation for the first few days.
It is important for patients to note that the effects of this
technique are temporary and the amount of correction will
diminish over time. Patients who are interested in this option
should discuss their expectations for length of time correction
is viable with their ophthalmologists.
1. Claringbold TV 2nd.
Laser-assisted subepithelial keratectomy for the correction
of myopia. J Cataract Refract Surg 2002 Jan;28(1):18-22
2. Azar DT, Ang RT, Lee JB, Kato T, Chen CC, Jain S, Gabison
E, Abad JC. Laser subepithelial keratomileusis: electron microscopy
and visual outcomes of flap photorefractive keratectomy. Curr
Opin Ophthalmol 2001 Aug;12(4):323-8
3. Kornilovsky IM. Clinical results after subepithelial photorefractive
keratectomy (LASEK). J Refract Surg 2001 Mar-Apr;17(2 Suppl):S222-3
4. Scerrati E. Laser in situ keratomileusis vs. laser epithelial
keratomileusis (LASIK vs. LASEK). J Refract Surg 2001 Mar-Apr;17(2
Suppl):S219-21
5. Lee JB, Seong GJ, Lee JH, Seo KY, Lee YG, Kim EK. Comparison
of laser epithelial keratomileusis and photorefractive keratectomy
for low to moderate myopia. J Cataract Refract Surg 2001 Apr;27(4):565-70
|